CVS Health Corp. (CVS)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for CVS is $111.66, 20.9% above the last close of $92.36 on Oct 16, 2026; targets range from $91.34 to $124.30. Rating consensus: Buy.
Snapshot
- P/E24.4x
- P/E vs sector-13.2%
- P/E vs own-69.0%
- Target upside+20.9%
- ConsensusBuy
- Market cap$118B
- FCF yield+10.0%
- InsidersNone in 90d
- Earnings in19d
- News
Why it moved
CVS Health Corp. (CVS) fell 0.2% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
1 story on the day (30-day average 1.8).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $92.36 · +17.1% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▼ 200▲
- Above MAs3 of 4 above
- MA20×50↑ in ~31d
- RSI58
- Support-3.6%
- Resistance+0.9%
- Off 52w high-16.0%
- Off ATH-16.0%
- 52w range$92.36
- Bollingerabove upper
- MACD0.99
- ATR+2.5%
- Volume0.7x
Analyst price targets
16 firms with a target in the last 12 months · last close $92.36 · as of Oct 16, 2026
Strong buy 7 · Buy 18 · Hold 2 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +7.3% year over year, free cash flow 5.3% of revenue, operating margin 4.4%.
| Q2 FY2026 | Jun 30, 2026 | $106B | 2.31 | $5.65B | 14.8% | 4.4% | 2.8% |
| Q1 FY2026 | Mar 31, 2026 | $100B | 2.30 | $3.4B | 15.6% | 4.7% | 2.9% |
| Q4 FY2025 | Dec 31, 2025 | $106B | 2.30 | $2.61B | 12.8% | 2.0% | 2.8% |
| Q3 FY2025 | Sep 30, 2025 | $103B | -3.13 | $98M | 13.4% | -3.1% | -3.9% |
| Q2 FY2025 | Jun 30, 2025 | $98.92B | 0.80 | $1.29B | 13.7% | 2.4% | 1.0% |
| Q1 FY2025 | Mar 31, 2025 | $94.59B | 1.41 | $3.81B | 15.2% | 3.6% | 1.9% |
| Q4 FY2024 | Dec 31, 2024 | $97.71B | 1.30 | $1.09B | 13.2% | 2.4% | 1.7% |
| Q3 FY2024 | Sep 30, 2024 | $95.43B | 0.07 | -$1.42B | 13.2% | 0.9% | 0.1% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $401.43 | -1.3% | -7.4% | +14.6% | 22.9 | $360B | |
| 2 |  | $94.75 | -0.7% | -7.1% | +4.0% | 23.3 | $121B | |
| 3 | | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | |
| 4 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 5 |  | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | |
| 6 |  | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 7 |  | $413.16 | -4.4% | -4.7% | +15.7% | 39.1 | $49.63B | |
| 8 |  | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.